PTC Therapeutics

Patent cliffs & loss of exclusivity

A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.

Company

AngelList URLhttps://angel.co/ptc-therapeutics
CAGE Code1XUQ0
Legal NamePTC Therapeutics Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/ptc-therapeutics
Email format{f}{last}
Facebook URLhttps://www.facebook.com/pages/PTC-Therapeutics/106075039423774
Fax Number908 222 7231

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  2. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  3. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  4. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  5. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  6. KEBILIDIeladocagene exuparvovec-tneqBiologicNov 2036
  7. SEPHIENCESEPIAPTERINSmall mol.Mar 2042
  8. SEPHIENCESEPIAPTERINSmall mol.Mar 2042

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.